These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6292818)
1. Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist. Christensen AV; Svendsen O; Krogsgaard-Larsen P Pharm Weekbl Sci; 1982 Oct; 4(5):145-53. PubMed ID: 6292818 [TBL] [Abstract][Full Text] [Related]
2. Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesia. Gerlach J; Bjørndal N; Christensson E Psychopharmacology (Berl); 1984; 82(1-2):131-4. PubMed ID: 6420823 [TBL] [Abstract][Full Text] [Related]
3. The GABA agonist THIP, attenuates antinociception in the mouse by modifying central cholinergic transmission. Zorn SH; Enna SJ Neuropharmacology; 1987 May; 26(5):433-7. PubMed ID: 3037414 [TBL] [Abstract][Full Text] [Related]
4. 4,5,6,7-Tetrahydroisothiazolo[5,4-c]pyridin-3-ol and related analogues of THIP. Synthesis and biological activity. Krogsgaard-Larsen P; Mikkelsen H; Jacobsen P; Falch E; Curtis DR; Peet MJ; Leah JD J Med Chem; 1983 Jun; 26(6):895-900. PubMed ID: 6304315 [TBL] [Abstract][Full Text] [Related]
5. Effect of repeated treatment with a gamma-aminobutyric acid receptor agonist on postnatal neural development in rats. Meier E; Jørgensen OS; Schousboe A J Neurochem; 1987 Nov; 49(5):1462-70. PubMed ID: 3668533 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the responses to the GABA-mimetics, THIP and piperidine-4-sulphonic acid, by agents which interact with benzodiazepine receptors. An electrophysiological study on cultured mouse neurones. Jensen MS; Lambert JD Neuropharmacology; 1984 Dec; 23(12A):1441-50. PubMed ID: 6098852 [TBL] [Abstract][Full Text] [Related]
7. Microiontophoretically applied THIP effects upon nociceptive responses of neurons in medial thalamus. Reyes-Vázquez C; Dafny N Appl Neurophysiol; 1983; 46(5-6):254-60. PubMed ID: 6329094 [TBL] [Abstract][Full Text] [Related]
8. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilisation. Kelly PA; McCulloch J J Neurochem; 1982 Sep; 39(3):613-24. PubMed ID: 7097270 [TBL] [Abstract][Full Text] [Related]
9. THIP inhibits feeding behavior in fasted rats. Blavet N; De Feudis FV; Clostre F Psychopharmacology (Berl); 1982; 76(1):75-8. PubMed ID: 6281838 [TBL] [Abstract][Full Text] [Related]
10. Inducing anesthesia with a GABA analog, THIP. Cheng SC; Brunner EA Anesthesiology; 1985 Aug; 63(2):147-51. PubMed ID: 3161425 [TBL] [Abstract][Full Text] [Related]
11. GABA-agonist therapy for Alzheimer's disease. Mohr E; Bruno G; Foster N; Gillespie M; Cox C; Hare TA; Tamminga C; Fedio P; Chase TN Clin Neuropharmacol; 1986; 9(3):257-63. PubMed ID: 2872956 [TBL] [Abstract][Full Text] [Related]
12. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188 [TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effect of the GABAmimetic 4,5,6,7-tetrahydroisoxazolo [5, 4-c]pyridin-3-ol (THIP): chronic treatment increases alpha-2 adrenoceptors in the mouse brain. Costa LG; Murphy SD J Pharmacol Exp Ther; 1984 May; 229(2):386-90. PubMed ID: 6325663 [TBL] [Abstract][Full Text] [Related]
14. The effect of the GABA-A agonist THIP on regional cortical blood flow in humans. A new test of hemispheric dominance. Roland PE; Friberg L J Cereb Blood Flow Metab; 1988 Jun; 8(3):314-23. PubMed ID: 3366794 [TBL] [Abstract][Full Text] [Related]
15. THIP treatment of Huntington's disease. Foster NL; Chase TN; Denaro A; Hare TA; Tamminga CA Neurology; 1983 May; 33(5):637-9. PubMed ID: 6221200 [TBL] [Abstract][Full Text] [Related]
16. Lack of GABAergic modulation of acetylcholine turnover in the rat thalamus. Cosi C; Wood PL Neurosci Lett; 1988 May; 87(3):293-6. PubMed ID: 2837692 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the analgesic activities of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) and 6-chloro-2[1-piperazinyl]pyrazine (MK 212). Murray TF; McGill W; Cheney DL Eur J Pharmacol; 1983 Jun; 90(2-3):179-84. PubMed ID: 6873180 [TBL] [Abstract][Full Text] [Related]
18. GABAergic actions of THIP in vivo and vitro: a comparison with muscimol and GABA. Waszczak BL; Hruska RE; Walters JR Eur J Pharmacol; 1980 Jul; 65(1):21-9. PubMed ID: 7398775 [TBL] [Abstract][Full Text] [Related]
19. Effects of inhibitors of protein synthesis and intracellular transport on the gamma-aminobutyric acid agonist-induced functional differentiation of cultured cerebellar granule cells. Belhage B; Hansen GH; Meier E; Schousboe A J Neurochem; 1990 Oct; 55(4):1107-13. PubMed ID: 2168931 [TBL] [Abstract][Full Text] [Related]
20. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist. Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]